Otero MJ - Search Results

1

Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease.

Martín-Gutiérrez N, Sánchez-Hernández JG, Rebollo N, Pordomingo AF, Muñoz F, Otero MJ. Martín-Gutiérrez N, et al. Among authors: otero mj. Eur J Hosp Pharm. 2022 Jul;29(4):222-227. doi: 10.1136/ejhpharm-2020-002410. Epub 2020 Oct 28. Eur J Hosp Pharm. 2022. PMID: 33115797 Free PMC article.

2

Relationship between vedolizumab serum concentrations in the induction phase and early and sustained response in the first year of treatment in patients with ulcerative colitis.

Sánchez-Hernández JG, Rebollo N, Muñoz F, Padullés-Zamora N, Miarons M, Martín Gutiérrez N, Martín Gil M, Otero MJ. Sánchez-Hernández JG, et al. Among authors: otero mj. Farm Hosp. 2021 Dec 22;45(7):38-44. Farm Hosp. 2021. PMID: 35379109 English.

3

Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients.

Peña-Lorenzo D, Rebollo N, Sánchez-Hernández JG, Zarzuelo-Castañeda A, Vázquez-López L, Otero MJ, Pérez-Blanco JS. Peña-Lorenzo D, et al. Among authors: otero mj. Eur J Pharm Sci. 2022 Jan 1;168:106049. doi: 10.1016/j.ejps.2021.106049. Epub 2021 Oct 24. Eur J Pharm Sci. 2022. PMID: 34699939 Free article.

4

Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity.

Otero MJ, Toscano Guzmán MD, Galván-Banqueri M, Martinez-Sotelo J, Santos-Rubio MD. Otero MJ, et al. Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e41-e46. doi: 10.1136/ejhpharm-2019-002126. Epub 2020 May 8. Eur J Hosp Pharm. 2021. PMID: 32385069 Free PMC article.

5

Application of population pharmacokinetics to the optimization of theophylline therapy.

Otero MJ, Buelga DS, Vázquez MA, Barrueco M, Dominguez-Gil A. Otero MJ, et al. J Clin Pharm Ther. 1996 Apr;21(2):113-25. doi: 10.1111/j.1365-2710.1996.tb00009.x. J Clin Pharm Ther. 1996. PMID: 8809648

6

Valproate population pharmacokinetics in children.

Serrano BB, García Sánchez MJ, Otero MJ, Buelga DS, Serrano J, Domínguez-Gil A. Serrano BB, et al. Among authors: otero mj. J Clin Pharm Ther. 1999 Feb;24(1):73-80. doi: 10.1046/j.1365-2710.1999.00202.x. J Clin Pharm Ther. 1999. PMID: 10319910

7

Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds.

Pedraza-Nieto L, Beunza-Sola M, Rodríguez CA, Moreno E, Otero MJ. Pedraza-Nieto L, et al. Among authors: otero mj. Int J Clin Pharm. 2021 Aug;43(4):1123-1127. doi: 10.1007/s11096-021-01271-w. Epub 2021 May 2. Int J Clin Pharm. 2021. PMID: 33937971

8

Population pharmacokinetics of phenobarbital in Caucasian patients with epilepsy.

Teixeira-da-Silva P, Santos-Buelga D, Otero MJ, García MJ. Teixeira-da-Silva P, et al. Among authors: otero mj. Eur J Pharm Sci. 2020 Oct 1;153:105484. doi: 10.1016/j.ejps.2020.105484. Epub 2020 Jul 21. Eur J Pharm Sci. 2020. PMID: 32707172

9

TDM of theophylline--compliance evaluation.

Otero MJ, Martin A, Barrueco M, Garcia MJ, Dominguez-Gil A. Otero MJ, et al. J Clin Pharm Ther. 1988 Aug;13(4):273-80. doi: 10.1111/j.1365-2710.1988.tb00193.x. J Clin Pharm Ther. 1988. PMID: 3235477

10

Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients.

Teixeira-da-Silva P, Pérez-Blanco JS, Santos-Buelga D, Otero MJ, García MJ. Teixeira-da-Silva P, et al. Among authors: otero mj. Pharmaceutics. 2022 Apr 7;14(4):811. doi: 10.3390/pharmaceutics14040811. Pharmaceutics. 2022. PMID: 35456645 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page